Six months into the fiscal year, Congress has finally passed FY2024 appropriations. It was a painstaking process, which many expected to include policy victories that both sides could celebrate. Instead, the spring work...more
4/9/2024
/ Artificial Intelligence ,
Biotechnology ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicare ,
Mental Health ,
New Legislation ,
Pandemic ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Telehealth ,
Transparency
This is the sixth in our 2024 Year in Preview series examining important trends in white collar law and investigations in the coming year. We will be posting further installments in the series throughout the next several...more
3/8/2024
/ China ,
Corporate Governance ,
Critical Infrastructure Sectors ,
Drug Pricing ,
Educational Institutions ,
Energy Projects ,
Environmental Social & Governance (ESG) ,
Healthcare ,
Legislative Agendas ,
Medicare Advantage ,
New Legislation ,
New Regulations ,
Pharmaceutical Industry ,
Private Equity ,
Regulatory Agenda ,
Social Media ,
Supply Chain ,
Supply Shortages ,
White Collar Crimes
Following the landmark October 30, 2023 executive order on artificial intelligence (AI), the White House Office of Management and Budget (OMB) issued a draft memorandum to federal agency heads for the use of AI within their...more